Paper36733407
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis.
Li H and 8 others. Int J Nanomedicine, 2023. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis. Papers, record 36733407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36733407
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Tuberculosis, Central Nervous System | Major topic |
| Animals | |
| Mice | |
| Rifampin | |
| Endothelial Cells | |
| Peptides |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32400978 | Physiological and pathological insights into exosomes in the brain. | Zool Res | 2020 | https://conductscience.org/library/papers/32400978 | PubMed |
| 2 | 29982104 | NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. | Biomaterials | 2018 | https://conductscience.org/library/papers/29982104 | PubMed |
| 3 | 31337761 | The generation and use of recombinant extracellular vesicles as biological reference material. | Nat Commun | 2019 | https://conductscience.org/library/papers/31337761 | PubMed |
| 4 | 35085105 | High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35085105 | PubMed |
| 5 | 31899467 | Angiopep-2 conjugated nanoparticles loaded with doxorubicin for the treatment of primary central nervous system lymphoma. | Biomater Sci | 2020 | https://conductscience.org/library/papers/31899467 | PubMed |
| 6 | 34011362 | Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34011362 | PubMed |
| 7 | 22780955 | Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. | Adv Drug Deliv Rev | 2013 | https://conductscience.org/library/papers/22780955 | PubMed |
| 8 | 32128074 | Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p. | J Extracell Vesicles | 2020 | https://conductscience.org/library/papers/32128074 | PubMed |
| 9 | 33162028 | Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/33162028 | PubMed |
| 10 | 33915184 | Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment. | Int J Pharm | 2021 | https://conductscience.org/library/papers/33915184 | PubMed |
| 11 | 28411185 | Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate. | Clin Microbiol Infect | 2017 | https://conductscience.org/library/papers/28411185 | PubMed |
| 12 | 30225516 | Central Nervous System Tuberculosis : Etiology, Clinical Manifestations and Neuroradiological Features. | Clin Neuroradiol | 2019 | https://conductscience.org/library/papers/30225516 | PubMed |
| 13 | 31684046 | Biodistribution of Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Radiation Injury Bone Marrow Murine Model. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31684046 | PubMed |
| 14 | 35524277 | Application of lipid nanovesicle drug delivery system in cancer immunotherapy. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/35524277 | PubMed |
| 15 | 31721318 | N-cadherin Restrains PTH Activation of Lrp6/β-catenin Signaling and Osteoanabolic Action. | J Bone Miner Res | 2019 | https://conductscience.org/library/papers/31721318 | PubMed |
| 16 | 30107337 | Angiopep-2 modified PEGylated 2-methoxyestradiol micelles to treat the PC12 cells with oxygen-glucose deprivation/reoxygenation. | Colloids Surf B Biointerfaces | 2018 | https://conductscience.org/library/papers/30107337 | PubMed |
| 17 | 33262592 | Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/33262592 | PubMed |
| 18 | 33718671 | Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss. | Bioact Mater | 2021 | https://conductscience.org/library/papers/33718671 | PubMed |
| 19 | 33105857 | Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/33105857 | PubMed |
| 20 | 26888041 | Development and regulation of exosome-based therapy products. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2016 | https://conductscience.org/library/papers/26888041 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42389066 | Metabolic Dysfunction-Associated Fatty Liver Disease: From Pathogenesis to Treatment. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42389066 | PubMed |
| 42348056 | The Biological Basis, Mechanisms of Action, and Optimization Strategies of Exosomes Derived from Mesenchymal Stem Cells for the Treatment of Alzheimer's Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42348056 | PubMed |
| 42238052 | Antibacterial Potential of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Against Clostridium Perfringens: An Experimental In Vitro and In Silico Study. | Iran J Med Sci | 2026 | https://conductscience.org/library/papers/42238052 | PubMed |
| 42126515 | Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson's Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42126515 | PubMed |
| 42035162 | Overcoming blood-brain barrier and chemoresistance in glioblastoma by Angiopep-2-modified NK cell-derived extracellular vesicles for targeted delivery of temozolomide. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42035162 | PubMed |
| 41878127 | Strategies, Challenges and Application Prospects for Exosome Engineering Modifications in Tumor Targeted Therapeutics. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41878127 | PubMed |
| 41712115 | Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41712115 | PubMed |
| 41599152 | Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41599152 | PubMed |
| 41598998 | Alterations in the Immune Response in Individuals with Latent Tuberculosis Infection. | Pathogens | 2025 | https://conductscience.org/library/papers/41598998 | PubMed |
| 41465211 | Overcoming Antibiotic Resistance and Treating Bacterial Infections with Biological Nanoparticles. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465211 | PubMed |
| 41428269 | ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy. | J Neurooncol | 2025 | https://conductscience.org/library/papers/41428269 | PubMed |
| 41356707 | Actively Targeted Nanoparticles for Enhanced Diagnosis, Treatment, and Vaccination of Tuberculosis: A Systematic Review. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41356707 | PubMed |
| 40649956 | Extracellular Vesicles Released by Bovine Alphaherpesvirus 1-Infected A549 Cells May Limit Subsequent Infections of the Progeny Virus. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649956 | PubMed |
| 40573239 | Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40573239 | PubMed |
| 40214500 | Targeting of Extracellular Vesicle-Based Therapeutics to the Brain. | Cells | 2025 | https://conductscience.org/library/papers/40214500 | PubMed |
| 39911262 | An Injectable Hydrogel Bioimplant Loaded with Engineered Exosomes and Triple Anti-Tuberculosis Drugs with Potential for Treating Bone and Joint Tuberculosis. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39911262 | PubMed |
| 39185334 | Engineered extracellular vesicles coated with an antimicrobial peptide for advanced control of bacterial sepsis. | J Extracell Biol | 2024 | https://conductscience.org/library/papers/39185334 | PubMed |
| 38846947 | Current landscape of exosomes in tuberculosis development, diagnosis, and treatment applications. | Front Immunol | 2024 | https://conductscience.org/library/papers/38846947 | PubMed |
| 38482902 | Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma. | Kaohsiung J Med Sci | 2024 | https://conductscience.org/library/papers/38482902 | PubMed |
| 38454402 | Periodontal ligament stem cell-derived exosome-loaded Emodin mediated antimicrobial photodynamic therapy against cariogenic bacteria. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/38454402 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ANG | 283 | PubTator's text mining | https://conductscience.org/library/genes/283 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36733407
GET https://conductscience.org/api/papers/v1/36733407/references?page=2